PharmEng International loses $250,952 in Q2, gets $1.6M in new contracts

TORONTO (CP) - PharmEng International Inc. lost $250,952 or 0.7 cents per share in the second quarter, after the consulting and contract drug manufacturing company went public in April. Revenues for the three months ended June 30 amounted to $2.2 million, compared to $1....More